Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11387542 | chr2:242563008 | G/GA | 9.7E-11 | 171 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs113885001 | chr16:8767255 | G/C | 1.11E-16 | 173 | 25.6 | 21.95 | 3.17 | KM Plot |
PCPG | rs113891197 | chr13:114151860 | C/T | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs113897472 | chr2:61580710 | G/T | 7.75E-5 | 174 | 21.95 | 32.03 | 10.3 | KM Plot |
PCPG | rs113931032 | chr10:69811676 | T/G | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs11394619 | chr3:80583607 | G/GA | 6.33E-5 | 177 | 19.53 | 24.53 | 27.4 | KM Plot |
PCPG | rs113948318 | chr8:53847247 | C/T | 0.000471 | 172 | 24.47 | 27.2 | 6.1 | KM Plot |
PCPG | rs11397853 | chr2:242529110 | G/GA | 5.02E-5 | 175 | 25.87 | 27.62 | 20.2 | KM Plot |
PCPG | rs113991755 | chr13:114166284 | C/T | 4.79E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs11400708 | chr1:56332084 | T/TC | 1.72E-7 | 175 | 25.7 | 25.77 | 13.27 | KM Plot |
PCPG | rs114033893 | chr2:240712874 | G/C | 4.72E-9 | 173 | 26.92 | 23.43 | 6.25 | KM Plot |
PCPG | rs114050845 | chr2:24318768 | G/A | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |
PCPG | rs114099267 | chr2:121547407 | C/T | 0.000225 | 176 | 25.53 | 24.23 | 59.77 | KM Plot |
PCPG | rs11412359 | chr16:89583628 | T/TG | 0.000269 | 177 | 26.78 | 25.67 | 19.25 | KM Plot |
PCPG | rs1142004 | chr13:114180446 | C/T | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |